Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 720672Generated: October 28, 2026

Triphenylphosphine → HCID 69663742, compound

https://huagongshe.com/reaction/720672

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriphenylphosphineHCID 11776—
ReactantChlorosuccinimideHCID 31398—
Reactant4-Methyl-1,2,3-thiadiazole-5-carboxylic acidHCID 1381992—
Reactant3-Cyclopropylmethyl-8-[4-(methylamino)-benzyl]-1-(2-fluorobenzyl)-3,7-dihydropurine-2,6-dioneHCID 21891691—
SolventDichloromethaneHCID 6344—
ProductHCID 69663742HCID 6966374215.6%

Reaction Conditions

Temperature0 °C

Reaction Steps

A mixture of 4-methyl-[l,2,3]thiadiazole-5-carboxylic acid (12 mg, 0.08 mmol) in dichloromethane (2.0 mL) cooled to 0° C. was treated with triphenylphosphine (27 mg , 0.10 mmol), and N-chlorosuccinimide (14 mg, 0.10 mmol). This mixture was stirred at 0° C. for 30 min and at 25° C. for 10 min. At this time, the reaction was treated with 3-cyclopropylmethyl-1-(2-fluoro-benzyl)-8-(4-methylamino-benzyl)-3,7-dihydro-purine-2,6-dione ( 75 mg, 0.17 mmol). The reaction was then stirred at 25° C. for 18 h. At this time, the reaction was diluted with dichloromethane. The organics were washed with a saturated aqueous sodium bicarbonate solution. This solution was extracted with a 90/10 dichloromethane/methanol solution. The organics were dried over magnesium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by HPLC (15–60% acetonitrile/water (0.075% trifluoroacetic acid in both solvents) over 40 min). Fractions with the desired product were combined and concentrated in vacuo. The resulting residue was diluted with dichloromethane (100 mL) and was washed with a saturated aqueous sodium bicarbonate solution (25 mL). The aqueous layer was re-extracted with dichloromethane (1×50 mL). The combined organics were dried over magnesium sulfate, filtered, and concentrated in vacuo. The resulting solid was dried in vacuo for 24 h to afford 4-methyl-[1,2,3]thiadiazole-5-carboxylic acid {4-[3-cyclopropylmethyl-1-(2-fluoro-benzyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl]-phenyl}-methyl-amide (7.0 mg, 14.5%) as a white solid: 1H NMR (DMSO-d6, 300 MHz) δ13.14 (broad s, 1H), 6.92–6.67 (m, 8H), 4.75 (s, 2H), 3.70 (s, 2H), 3.47 (d, J=7.32 Hz, 2H), 2.99 (s, 3H), 2.26 (s, 3H), 0.82 (m, 1H), 0.03 (m, 4H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07135475B2
Source datasetuspto-grants-2006_11
ORD IDord-6f1f84c02ac145df9cbf3ed6ddbbb978
Source noteuspto-grants-2006_11